Zomedica Corp. (ZOM) Financials

AMEX Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0.09
Day's range
$0.1
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201920192020202020212021202220222023202320242024202520250%0%-100%-100%-200%-200%-300%-300%-400%-400%-500%-500%Profit Margin
Profit Margin
Revenue
Earnings

ZOM Income statement / Annual

Last year (2025), Zomedica Corp.'s total revenue was $27.29 M, an increase of 8.33% from the previous year. In 2025, Zomedica Corp.'s net income was -$46.98 M. See Zomedica Corp.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2025 FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $27.29 M $25.19 M $18.93 M $4.13 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $8.20 M $7.87 M $5.28 M $1.08 M $530.02 K $787.61 K $205.77 K $92.41 K $45.82 K $0.00
Gross Profit $19.09 M $17.32 M $13.65 M $3.05 M -$530.02 K -$787.61 K -$205.77 K -$92.41 K -$45.82 K $0.00
Gross Profit Ratio 0.7 0.69 0.72 0.74 0 0 0 0 0 0
Research and Development Expenses $7.27 M $5.74 M $2.58 M $1.67 M $8.04 M $10.35 M $10.32 M $2.75 M $1.52 M $758.05 K
General & Administrative Expenses $29.66 M $29.03 M $22.93 M $0.00 $7.93 M $8.18 M $5.83 M $5.08 M $4.24 M $1.43 M
Selling & Marketing Expenses $17.19 M $14.14 M $9.88 M $0.00 $261.91 K $471.89 K $225.89 K $164.25 K $194.19 K $143.47 K
Selling, General & Administrative Expenses $46.85 M $43.17 M $33.00 M $22.75 M $8.19 M $8.65 M $6.06 M $5.24 M $4.43 M $1.57 M
Other Expenses $16.02 M $0.00 -$7.00 K $6.00 K $530.02 K $787.61 K $205.77 K $92.41 K $45.82 K $0.00
Operating Expenses $70.14 M $48.91 M $35.58 M $24.43 M $16.76 M $19.78 M $16.58 M $8.08 M $6.00 M $2.28 M
Cost And Expenses $78.34 M $56.78 M $40.85 M $25.51 M $16.76 M $19.78 M $16.58 M $8.08 M $6.00 M $2.28 M
Interest Income $3.97 M $5.46 M $2.70 M $357.45 K $32.86 K $18.34 K $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $175.00 K $1.00 K $6.05 K $732.00 $18.34 K $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $7.99 M $6.30 M $4.04 M $1.14 M $530.02 K $787.61 K $205.77 K $92.41 K $45.82 K $9.05 K
EBITDA -$39.55 M -$29.39 M -$15.34 M -$19.57 M -$16.38 M -$19.00 M -$16.44 M -$7.97 M -$5.97 M -$2.28 M
EBITDA Ratio -1.45 -1.17 -0.81 -4.74 0 0 0 0 0 0
Operating Income Ratio -1.87 -1.25 -1.16 -5.17 0 0 0 0 0 0
Total Other Income/Expenses Net $3.51 M -$4.27 M $2.54 M $657.78 K -$146.81 K $273.00 -$68.44 K $18.98 K $258.06 K $7.44 K
Income Before Tax -$47.54 M -$35.86 M -$19.38 M -$20.72 M -$16.91 M -$19.78 M -$16.65 M -$8.07 M -$6.01 M -$2.28 M
Income Before Tax Ratio -1.74 -1.42 -1.02 -5.01 0 0 0 0 0 0
Income Tax Expense -$557.00 K -$1.33 M -$2.37 M -$2.33 M $9.33 K $38.08 K $136.88 K -$18.98 K $28.59 K $0.00
Net Income -$46.98 M -$34.53 M -$17.02 M -$18.38 M -$16.92 M -$19.82 M -$16.65 M -$8.07 M -$6.01 M -$2.28 M
Net Income Ratio -1.72 -1.37 -0.9 -4.45 0 0 0 0 0 0
EPS -0.048 -0.0352 -0.0174 -0.0192 -0.0464 -0.19 -0.18 -0.0923 -0.075 -0.0493
EPS Diluted -0.048 -0.0352 -0.0174 -0.0192 -0.0464 -0.19 -0.18 -0.0923 -0.075 -0.0493
Weighted Average Shares Out $979.95 M $979.95 M $979.92 M $956.53 M $364.44 M $106.30 M $92.49 M $87.40 M $80.16 M $46.23 M
Weighted Average Shares Out Diluted $979.95 M $979.95 M $979.92 M $956.53 M $364.44 M $106.30 M $93.44 M $87.40 M $80.16 M $46.23 M
Link